CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Boehringer Ingelheim Pharmaceuticals, Inc. et al. vs. Genentech, Inc.

Explore the PTAB proceeding IPR2017-02031 filed by Boehringer Ingelheim Pharmaceuticals, Inc. et al. on 2017-08-31. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2017-02031

Filing Date

2017-08-31

Accorded Filing Date

2017-08-31

Institution Decision Date

2018-03-29

Last Modified Date

2024-01-11

Proceeding Type

IPR

Termination Date

2018-07-31

Trial Status

Terminated

Parties & Counsel

Patent Owner / Respondent

Patent Information

1 Patent Involved
Respondent Application Number 08146206
Respondent Patent Number 6407213
Legal Expiration Date
2020-06-30 Expired (Term Ended)
Patent Term Adjustment (PTA) +2937 Days Awarded
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred
Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Tribunal & APJ Panel Intelligence

Board Intelligence

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Decisions Rendered

1 Total

Proceeding Status

Terminated

Board Decisions & Rulings (1)

Termination 2018-07-31
Termination Decision Document
37 CFR 42.72

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 6 proceedings
πŸ›οΈ
USPTO PTAB Trials 8 proceedings
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (1): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (14 found):
PTAB: 8 U.S. Courts: 6
USPTO PTAB Trial 2017-09-29
IPR2017-02139

Samsung Bioepis Co., Ltd. v. Genentech, Inc.

Asserted Patent
Status: Final Written Decision
USPTO PTAB Trial 2017-08-31
IPR2017-02032

Boehringer Ingelheim Pharmaceuticals, Inc. et al. v. Genentech, Inc.

Asserted Patent
Status: Terminated
USPTO PTAB Trial 2017-05-25
IPR2017-01488

Pfizer, Inc. v. Genentech, Inc.

Asserted Patent
Status: Final Written Decision
USPTO PTAB Trial 2017-05-25
IPR2017-01489

Pfizer, Inc. v. Genentech, Inc.

Asserted Patent
Status: Final Written Decision
USPTO PTAB Trial 2017-05-08
IPR2017-01374

Celltrion Inc. et al. v. Genentech, Inc.

Asserted Patent
Status: Final Written Decision
USPTO PTAB Trial 2017-05-08
IPR2017-01373

Celltrion Inc. et al. v. Genentech, Inc.

Asserted Patent
Status: Final Written Decision
USPTO PTAB Trial 2016-08-30
IPR2016-01694

Mylan Pharmaceuticals Inc. et al. v. Genentech, Inc.

Asserted Patent
Status: Terminated-Settled
USPTO PTAB Trial 2016-08-30
IPR2016-01693

Mylan Pharmaceuticals Inc. et al. v. Genentech, Inc.

Asserted Patent
Status: Terminated-Settled
U.S. District Court 2019-04-05
1:19-cv-00638

Genentech, Inc. v. Pfizer Inc.

Asserted Patent
Status: DED
U.S. District Court 2019-03-29
1:19-cv-00602

Genentech, Inc. v. Immunex Rhode Island Corp.

Asserted Patent
Status: DED
U.S. District Court 2018-09-04
1:18-cv-01363

Genentech, Inc. v. Samsung Bioepis Co., Ltd.

Asserted Patent
Status: DED
U.S. District Court 2018-01-12
1:18-cv-00095

Genentech, Inc. v. Celltrion, Inc.

Asserted Patent
Status: DED
U.S. District Court 2017-10-18
1:17-cv-01471

Genentech, Inc. v. Amgen, Inc.

Asserted Patent
Status: DED
U.S. District Court 2017-10-06
1:17-cv-01407

Genentech, Inc. v. Amgen Inc.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Proceeding Documents

189
32

Termination Decision Document Paper

2018-07-31 FILING PARTY: BOARD
31

Petitioner's Request for Adverse Judgment Paper

2018-07-24 FILING PARTY: PETITIONER
30

Joint Notice of Stipulation Paper

2018-07-19 FILING PARTY: PATENT OWN
29

Patent Owner's Notice of Deposition Geoffrey Hale Paper

2018-07-19 FILING PARTY: PATENT OWN
28

Decision - Denying Patent Owner's Request for Rehearing - 37 CFR 42.71(d) Paper

2018-07-06 FILING PARTY: BOARD

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc